| | The first author | Year | Study interval | Region | Race | Setting | Model | Antiviral therapy | Sample size |
| 1 | Wong, G. L. | 2013 | 2005.12–2012.8 | China | Asian | Hospital | CU-HCC, GAG-HCC, and REACH-B | Entecavir | 1531 | 2 | Abu-Amara, Mahmoud | 2016 | — | Canada | Asian, Caucasian, and African | Hospital | CU-HCC, GAG-HCC, and REACH-B | Nucleotide analog, interferon | 2105 | 3 | Arends, P. | 2015 | 2005–2013.5 | European | Asian, Caucasian | Hospital | CU-HCC, GAG-HCC, and REACH-B | Entecavir | 744 | 4 | Lee, Hye Won | 2019 | 2010–2016 | Korea | Asian | Hospital | CU-HCC, GAG-HCC, PAGE-B, mPAGE-B, and REACH-B | Entecavir, tenofovir, and lamivudine | 1330 | 5 | Jeon, Mi Young | 2018 | 2006–2014 | Korea | Asian | Hospital | CU-HCC, REACH-B, and mREACH-B | No-classification | 1397 | 6 | Papatheodoridis, George V. | 2015 | — | Greece, Italy Spain, The Netherlands, and Turkey | Caucasian | Hospital | CU-HCC, GAG-HCC, and REACH-B | Entecavir, tenofovir, | 1666 | 7 | Kim, G. A. | 2015 | 1997.1.1–2012.12.31 | Korea | Asian | Hospital | CU-HCC | None | 829 | 8 | Kim, Ji Hyun | 2018 | 2007.1–2016.6 | Korea | Asian | Hospital | CU-HCC, GAG-HCC, PAGE-B, mPAGE-B, and REACH-B | Entecavir, tenofovir | 1000 | 9 | Brouwer, W. P. | 2017 | 1985–2012 | Rotterdam, The Netherlands | Asian, Caucasian, and African | Hospital | CU-HCC, GAG-HCC, PAGE-B, and REACH-B | No-classification | 557 | 10 | Yang, H. I. | 2019 | 1997–2016 | American, Asian-Pacific region | Asian American, and Asian | Hospital | CU-HCC, GAG-HCC, PAGE-B, and mPAGE-B, REACH-B | Oral antiviral | 2683 | 11 | Jeon, M. Y. | 2017 | 2006.4–2014.12 | Korea | Asian | Hospital | CU-HCC, REACH-B, and mREACH-B | No-classification | 540 | 12 | Tawada, Akinobu | 2016 | 2000.11–2014.3 | Japan | Asian | Hospital | CU-HCC, GAG-HCC | Entecavir, lamivudine | 225 | 13 | Jung, K. S. | 2015 | 2006–2011 | Korea | Asian | Hospital | CU-HCC, GAG-HCC, REACH-B, and mREACH-B | No-classification | 1308 | 14 | Kim, M. N. | 2017 | 2006.8–-2015.1 | Korea | Asian | Hospital | CU-HCC, GAG-HCC, PAGE-B, and REACH-B | Entecavir, tenofovir | 1092 | 15 | Riveiro-Barciela, M. | 2017 | 2005.4–2015.09 | Spain | Caucasian | Hospital | PAGE-B, | Emtricitabine, entecavir, tenofovir, and lamivudine | 611 | 16 | Seo, Yeon Seok | 2017 | 2006–2012 | Korea | Asian | Hospital | PAGE-B, REACH-B, and mREACH-B | — | 1241 | 17 | Magalhaes-Costa, Pedro | 2016 | 2006.1–2014.2 | Spain | Asian, Caucasian, and African | Hospital | REACH-B | Entecavir, tenofovir | 120 | 18 | Yang, H. I. | 2016 | — | China | Asian | Hospital | REACH-B | ERADICATE-B (none) CUHK (1/4) | ERADICATE-B (2688) CUHK(426) | 19 | Chen, T. M. | 2013 | 2006.1–2012.5 | China | Asian | Hospital | REACH-B | — | 904 | 20 | Chen, W. | 2015 | 2004.10.1–2014.5.1 | China | Asian | Hospital | REACH-B | — | 627 | 21 | Lee, H. W. | 2014 | 2007.2–2011.1 | Korea | Asian | Hospital | REACH-B | Entecavir | 192 | 22 | Yang, H. I. | 2011 | — | China, Korea | Asian | Hospital | REACH-B | None | 1505 |
|
|